Who owns HALOZYME THERAPEUTICS INC NOTE 1.000 8/1?
- CUSIP Number: 40637haf6
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics Inc Note 1.000 8/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics Inc Note 1.000 8/1 stock
Who bought or sold HALOZYME THERAPEUTICS INC NOTE 1.000 8/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| M&g Investment Management | 18B | $31M | 21% | Dec 2023 |
|
| Calamos Advisors | 64M | $59M | 0% | Dec 2023 |
|
| Wolverine Asset Management | 51M | $48M | 0% | Dec 2023 |
|
| MacKay Shields | 45M | $42M | -45% | Dec 2023 |
|
| Citadel Advisors | 33M | $31M | -31% | Dec 2023 |
|
| Polar Securities | 20M | $19M | 0% | Dec 2023 |
|
| Millennium Management | 16M | $14M | 100% | Dec 2023 |
|
| Bank Of Montreal | 14M | $13M | 265% | Dec 2023 |
|
| Kohlberg Kravis Roberts & Co | 13M | $12M | -13% | Dec 2023 |
|
| D. E. Shaw & Co | 12M | $11M | 64% | Dec 2023 |
|
| Absolute Investment Advisers | 11M | $11B | 0% | Mar 2024 |
|
| SSI Investment Management | 9.8M | $9.1M | -9% | Dec 2023 |
|
| CSS | 9.0M | $8.4M | 100% | Dec 2023 |
|
| Readystate Asset Management | 8.5M | $7.9M | 55% | Dec 2023 |
|
| CNH Partners | 8.2M | $7.7M | 100% | Dec 2023 |
|
| Amundi | 8.0M | $7.3M | 0% | Dec 2023 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 8.0M | $7.4M | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 6.7M | $6.2M | 35% | Dec 2023 |
|
| RWC Asset Management | 5.3M | $4.9M | 0% | Dec 2023 |
|
| Shenkman Capital Management | 5.2M | $5.0B | 25% | Dec 2023 |
|
| New York State Common Retirement Fund | 4.8M | $4.4M | -24% | Dec 2023 |
|
| Bank of America Corporation | 4.3M | $4.0M | 110% | Dec 2023 |
|
| Royal Bank of Canada | 3.9M | $3.6M | 16% | Dec 2023 |
|
| Palisade Capital Management | 3.9M | $3.6M | 0% | Dec 2023 |
|
| Man Group | 3.8M | $3.6M | -1% | Dec 2023 |
|
| Jane Street | 3.8M | $3.6M | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 3.4M | $3.1M | 83% | Dec 2023 |
|
| Wells Fargo & Company | 3.4M | $3.1M | -4% | Dec 2023 |
|
| Barclays | 3.1M | $2.9M | 100% | Dec 2023 |
|
| Flossbach Von Storch | 2.5M | $2.4M | 0% | Dec 2023 |
|
| Credit Suisse | 2.3M | $2.3M | -8% | Dec 2023 |
|
| OZ Management | 2.0M | $1.9M | 0% | Dec 2023 |
|
| Context Capital Management | 2.0M | $1.9B | 99900% | Dec 2023 |
|
| Jpmorgan Chase & Co | 2.0M | $1.8M | 41% | Dec 2023 |
|
| Agf Management | 1.1M | $1.0M | 0% | Dec 2023 |
|
| Citigroup | 1.1M | $993k | 1849% | Dec 2023 |
|
| Aviva | 1.0M | $929k | -80% | Dec 2023 |
|
| Bank of New York Mellon | 600k | $585k | 0% | Mar 2024 |
|
| Groupama Asset Managment | 600k | $561k | 100% | Dec 2023 |
|
| Zurcher Kantonalbank | 500k | $486k | 0% | Mar 2024 |
|
| Calamos Wealth Management | 286k | $266k | -20% | Dec 2023 |
|
| First Hawaiian Bank | 90k | $87k | -55% | Mar 2024 |
|
| SG Americas Securities | 39k | $3.6M | -2% | Dec 2023 |
|
| Balboa Wealth Partners | 33k | $31k | 0% | Dec 2023 |
|
| Nomura Holdings | 11k | $413k | 19% | Dec 2023 |
|
| Aurum Wealth Management Group | 11k | $10k | 100% | Dec 2023 |
|
| Candriam Luxembourg S.C.A. | 4.0k | $3.7M | 100% | Dec 2023 |
|
| UBS Group | 2.0k | $1.9k | 100% | Dec 2023 |
|
Who sold out of Halozyme Therapeutics Inc Note 1.000 8/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Sep 2023 | 3.3M | $3.1M |